Key Details
Price
$71.48PE Ratio
32.49Annual ROE
8.05%Beta
0.51Events Calendar
Next earnings date:
Apr 24, 2025Recent quarterly earnings:
Feb 19, 2025Recent annual earnings:
Feb 19, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 24, 25 Oppenheimer
OutperformFeb 20, 25 UBS
BuyFeb 20, 25 Scotiabank
Sector PerformFeb 20, 25 RBC Capital
Sector PerformFeb 20, 25 Piper Sandler
OverweightFeb 20, 25 Citigroup
NeutralFeb 20, 25 Cantor Fitzgerald
OverweightFeb 20, 25 B of A Securities
BuyDec 12, 24 Cantor Fitzgerald
OverweightNov 15, 24 Wolfe Research
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
BioMarin Pharmaceutical doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for BioMarin Pharmaceutical?
- Does BioMarin Pharmaceutical pay dividends?
- What sector is BioMarin Pharmaceutical in?
- What industry is BioMarin Pharmaceutical in?
- What country is BioMarin Pharmaceutical based in?
- When did BioMarin Pharmaceutical go public?
- Is BioMarin Pharmaceutical in the S&P 500?
- Is BioMarin Pharmaceutical in the NASDAQ 100?
- Is BioMarin Pharmaceutical in the Dow Jones?
- When was BioMarin Pharmaceutical's last earnings report?
- When does BioMarin Pharmaceutical report earnings?
- Should I buy BioMarin Pharmaceutical stock now?
What is the ticker symbol for BioMarin Pharmaceutical?
The ticker symbol for BioMarin Pharmaceutical is NASDAQ:BMRN
Does BioMarin Pharmaceutical pay dividends?
No, BioMarin Pharmaceutical does not pay dividends
What sector is BioMarin Pharmaceutical in?
BioMarin Pharmaceutical is in the Healthcare sector
What industry is BioMarin Pharmaceutical in?
BioMarin Pharmaceutical is in the Biotechnology industry
What country is BioMarin Pharmaceutical based in?
BioMarin Pharmaceutical is headquartered in United States
When did BioMarin Pharmaceutical go public?
BioMarin Pharmaceutical's initial public offering (IPO) was on July 26, 1999
Is BioMarin Pharmaceutical in the S&P 500?
No, BioMarin Pharmaceutical is not included in the S&P 500 index
Is BioMarin Pharmaceutical in the NASDAQ 100?
No, BioMarin Pharmaceutical is not included in the NASDAQ 100 index
Is BioMarin Pharmaceutical in the Dow Jones?
No, BioMarin Pharmaceutical is not included in the Dow Jones index
When was BioMarin Pharmaceutical's last earnings report?
BioMarin Pharmaceutical's most recent earnings report was on Feb 19, 2025
When does BioMarin Pharmaceutical report earnings?
The next expected earnings date for BioMarin Pharmaceutical is Apr 24, 2025
Should I buy BioMarin Pharmaceutical stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions